OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480 | -12.7% | 38,846 | -36.2% | 0.00% | – |
| Q2 2023 | $550 | +170.9% | 60,853 | +4.4% | 0.00% | – |
| Q1 2023 | $203 | +20.8% | 58,300 | -14.9% | 0.00% | – |
| Q4 2022 | $168 | -99.9% | 68,500 | 0.0% | 0.00% | – |
| Q3 2022 | $190,000 | -31.9% | 68,500 | 0.0% | 0.00% | – |
| Q2 2022 | $279,000 | -7.6% | 68,500 | -3.3% | 0.00% | – |
| Q1 2022 | $302,000 | -54.0% | 70,872 | +1.0% | 0.00% | – |
| Q4 2021 | $657,000 | +172.6% | 70,172 | +713.8% | 0.00% | – |
| Q2 2021 | $241,000 | -13.9% | 8,623 | +2.0% | 0.00% | – |
| Q1 2021 | $280,000 | – | 8,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $35,043,000 | 3.61% |
| BVF INC/IL | 7,411,503 | $69,372,000 | 2.52% |
| Kynam Capital Management, LP | 293,799 | $2,750,000 | 1.47% |
| Cormorant Asset Management, LP | 2,169,871 | $20,310,000 | 1.21% |
| VR Adviser, LLC | 816,651 | $7,644,000 | 1.04% |
| Vivo Capital, LLC | 1,689,515 | $15,814,000 | 0.95% |
| Octagon Capital Advisors LP | 231,417 | $2,166,000 | 0.42% |
| HighVista Strategies LLC | 50,942 | $477,000 | 0.38% |
| RA Capital Management | 2,150,404 | $20,128,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 500,000 | $4,700,000 | 0.31% |